Results

Total Results: 495 records

Showing results for "claims".
Users also searched for: health literacy

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
    May 21, 2015 - Use of claims data to examine the impact of length of inpatient psychiatric stay on readmission rate
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
    June 12, 2012 - The provided forest plots don't support the claims of statistically significant differences between
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth_research.pdf
    January 01, 2020 - that favor interventions such as cesarean22 • Amplified perception of risk of medico-legal liability claims
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
    January 30, 2014 - VU EPC DBD Protocol_AHRQ comments_revised_clean Evidence-based Practice Center Systematic Review Protocol Project Title: Psychosocial and Pharmacologic Interventions for Disruptive Behavior …
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_disposition-comments.pdf
    December 14, 2015 - Disposition of Comments for CER 157 Appendicitis Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Diagnosis of Right Lower Quadrant Pain and Suspected Acute Appendicitis Draft review available for public comment from November 4, 2014 to December 2, 2014. Re…
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
    April 01, 2013 - Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: PCA3 Testing for the Diagnosis and Management of Prostate Cancer. Draft review available for public comment from May …
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
    April 01, 2012 - Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1024 Published Online: April 2012 Comparative Effectiveness Research Review Disposition of Co…
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
    August 23, 2012 - Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1175 Published Online: August 23, 2012 Comparative Effectiveness Research Review Disposition of Comments …
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_executive.pdf
    September 01, 2012 - All of the studies assessed medication adherence using insurance claims data to measure either the
  10. effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
    January 01, 2018 - monitoring for AEs has been recommended for several years,12,16,29 there is evidence from Medicaid claims
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
    May 01, 2014 - Clinician concerns about participation • What knowledge is available from various data sources (e.g., claims
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/wiki-collaboration_research.pdf
    September 01, 2011 - Feasibility Study of a Wiki Collaboration Platform for Systematic Reviews Methods Research Report Feasibility Study of a Wiki Collaboration Platform for Systematic Reviews Methods Research Report Feasibility Study of a Wiki Collaboration Platform for Systematic Re…
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
    November 01, 2013 - 1 Comparative Effectiveness Review Number 126 Use of Natriuretic Peptide Measurement in the Management of Heart Failure Executive Summary Background Heart failure (HF) is a major concern for health care systems because of its chronic nature and resource implications. HF affects approximately 5.7 million Ameri…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
    November 01, 2013 - It summarizes and discusses the reviewer's analyses, the extent of evidence in support of claims, and
  16. effectivehealthcare.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
    May 27, 2016 - Peer reviewer #1 Background 13, 15: Claims provide littler basis for safety analyses.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
    January 01, 2014 - not mean that those interventions do not work; rather there was not quality data to sustain such claims
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-future_research.pdf
    August 09, 2012 - The perceived risk of malpractice claims and lawsuits are thought to influence clinician behavior, particularly
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
    May 01, 2013 - Comment Response Coyne, James Summary/Discussion/Conclusion [pg. 57]Applicability Repeating the usual claims
  20. CARDIOVASCULAR (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - intervals, to 20 mg, 40 mg, and up to the maximum recommended dose of 60 mg daily.58 The manufacturer claims

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: